BioScience Patent Translation
Reduce office actions and litigation risk.
Life is in the details.
For millennia, bioscience has harnessed biomolecular processes to enhance and develop techniques and products for basic human needs such as preserving food and creating fuel. The importance of getting the details correct cannot be understated. It’s the same with bioscience patent translation. You have to get the details perfect in order to succeed.
Today, bioscience has global reach in both geography and application. More than 35,000 biotechnology patent applications are filed each year through WIPO, and the trend is increasing. Rest assured, with MultiLing, you have subject matter experts who are trained with advanced science degrees and are ready to focus on the details for you.
Translators who know the science.
In the bioscience industry, you rely on the world’s top experts to create your intellectual property. With our translation services, you now have the world’s top language specialists—comprised of in-country native linguists, who are also scientists, engineers, and legal specialists—to help protect your IP around the world.
On top of that, you have access to the industry’s top technology platform, Savanta™, with advanced artificial intelligence to automate the repetitive parts of the process to increase efficiency and reduce costs.
Join other bioscience customers who have reduced office actions and litigation risk, and decreased time to grant, by engaging with MultiLing to manage their patent protection needs—including IP translation, patent translation, and patent filings.
Ryan Marshall, Patent Attorney and Managing Shareholder, Brinks.
“An effective IP translation service provider can leverage its resources and best practices in more jurisdictions than possible with one foreign agent, in part enabling patent rights in more geographic cases for the same cost — or even significantly lower.”
No matter the industry,
we’re ready to help.
When you’re ready for quality translation experts from your industry, so are we.